glp 1 and binge eating disorder New hope for bulimia: GLP-1 drugs could be the key New Insight: GLP‑1 medications—long used

* Correspondence: Xuejing Lu, [email protected] These authors have contributed equally to this work Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

10.1210/jc.2009-1503 26 Delgado-ArosS.KimD.-Y.BurtonD

Liesegang, T

The FDA label for Increlex explicitly warns of hypoglycaemia, intracranial hypertension, and slipped capital femoral epiphysis as serious adverse events

FIGURE 3 Protein-protein interaction networks and important genes of differentially expressed genes The PPI network of DEGs and its modules are shown in Figure 4